Endovascular treatment for superior vena cava obstruction in Behçet disease

J Vasc Surg. 2005 Mar;41(3):548-51. doi: 10.1016/j.jvs.2004.12.034.

Abstract

Behçet disease is a heterogeneous, multisystem inflammatory disorder; vascular involvement has been considered to result from systemic vasculitis, which most frequently affects veins and occurs in 5% to 10% of these patients. However, superior vena cava (SVC) involvement is rare; it accounts for only 6% of the cases. The aim of this article is to a report on a case of SVC recanalization through the use of fibrinolysis and self-expanding stents as treatment of life-threatening SVC syndrome in a young male patient with Behçet disease.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Behcet Syndrome / complications*
  • Behcet Syndrome / therapy
  • Catheterization*
  • Humans
  • Male
  • Plasminogen Activators / therapeutic use
  • Radiography
  • Stents*
  • Superior Vena Cava Syndrome / diagnostic imaging
  • Superior Vena Cava Syndrome / etiology
  • Superior Vena Cava Syndrome / therapy*
  • Thrombolytic Therapy
  • Urokinase-Type Plasminogen Activator / therapeutic use

Substances

  • Plasminogen Activators
  • Urokinase-Type Plasminogen Activator